Next Article in Journal
Application of New Polymer Soil Amendment in Ecological Restoration of High-Steep Rocky Slope in Seasonally Frozen Soil Areas
Next Article in Special Issue
Surface Modifications of Superparamagnetic Iron Oxide Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Methylene Blue Adsorbent Beads
Previous Article in Journal
Self-Neutralizing Melamine–Urea–Formaldehyde–Citric Acid Resins for Wood Panel Adhesives
Previous Article in Special Issue
Effect of Chitosan–Riboflavin Bioconjugate on Green Mold Caused by Penicillium digitatum in Lemon Fruit
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Surface Modifications of Silver Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Antibacterial Agents against Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella enterica

1
Department of Chemical Engineering, International University—Vietnam National University Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
2
Nanomaterials Engineering Research & Development (NERD) Laboratory, International University—Vietnam National University Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
3
School of Chemical and Environmental Engineering, International University—Vietnam National University Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
*
Author to whom correspondence should be addressed.
Polymers 2024, 16(13), 1820; https://doi.org/10.3390/polym16131820
Submission received: 22 May 2024 / Revised: 18 June 2024 / Accepted: 25 June 2024 / Published: 27 June 2024
(This article belongs to the Special Issue Research Progress on Chitosan Applications)

Abstract

:
In medicine, the occurrence of antibiotic resistance was becoming a critical concern. At the same time, traditional synthesis methods of antibacterial agents often lead to environmental pollution due to the use of toxic chemicals. To address these problems, this study applies the green synthesis method to create a novel composite using a polymer blend (M8) consisting of chitosan (CS), polyethylene glycol (PEG), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), and silver nanoparticles. The results show that the highest ratio of AgNO3:M8 was 0.15 g/60 mL, which resulted in a 100% conversion of Ag+ to Ag0 after 10 h of reaction at 80 °C. Hence, using M8, Ag nanoparticles (AgNPs) were synthesized at the average size of 42.48 ± 10.77 nm. The AgNPs’ composite (M8Ag) was used to inhibit the growth of Staphylococcus aureus (SA), Pseudomonas aeruginosa (PA), and Salmonella enterica (SAL). At 6.25% dilution of M8Ag, the growth of these mentioned bacteria was inhibited. At the same dilution percentage of M8Ag, PA was killed.

1. Introduction

Microorganisms have a significant impact on human health, particularly bacteria prevalent in numerous surroundings such as food and drinking water, among the most common of which are Staphylococcus aureus (SA), Pseudomonas aeruginosa (PA), and Salmonella enterica (SAL). All of them can cause infections, ranging in intensity and variety, from skin infections to gastrointestinal and respiratory infections [1,2,3].
Staphylococcus aureus (SA) is a Gram-positive cocci in the Micrococcaceae family which develops gleaming, smooth, complete, elevated, and transparent colonies with a golden color and 1 to 4 mm in diameter [4]. SA generates tissue-degrading enzymes such as protease, lipase, and hyaluronidase [5]. These bacterial metabolites may help in the spread of infection to nearby tissues. S. aureus has a predisposition for spreading to certain organs, including the bones, joints, kidneys, and lungs [6]. In addition, SA can cause skin infections (such as boils and cellulitis), respiratory infections, and food poisoning [7].
Pseudomonas aeruginosa (PA) is a Gram-negative, heterotrophic, motile bacteria of the Pseudomonadaceae family [8]. PA is a rod-shaped bacteria of around 1–5 µm in length and 0.5–1.0 µm in width [8] that forms large, opaque, flat colonies with uneven borders. It is known to cause opportunistic infections, especially in people with weaker immune systems or cystic fibrosis [8]. P. aeruginosa has the potential to cause infections in a variety of organs, including the lungs, urinary tract, and skin. On the clinical level, patients with impaired immune systems, including patients with cystic fibrosis, HIV/AIDS, cancer, burn and eye injuries, and non-healing diabetic wounds, are at greatest risk [8].
Salmonella enterica (SAL), as a group, is a Gram-negative, non-spore-forming prokaryote belonging to the Enterobacteriaceae family [9]. Salmonella range in size from 0.7–1.5 mm to 2.2–5.0 mm, and colonies commonly measure 2–4 mm in diameter [10]. SAL infection can cause a systemic illness known as enteric fever, an intestinal infection known as gastroenteritis, or a blood infection in humans known as bacteremia [11].
SA, PA, and SAL growth can be inhibited, or these bacteria can even be killed, using antibiotics [12,13]. However, using antibiotics can cause antibiotic resistance (ABR) [14]. Hence, a material that could inhibit the growth of these bacteria, or even kill these bacteria, without causing ABR phenomena would be ideal. To achieve this, researchers used various antibacterial agents that were not conventional and/or traditional antibiotics such as polymers, metal oxides, or other types of composites. One of the most common antibacterial agents are metal oxides and other metal-type particles such as silver particles [2,3,15,16,17,18], iron oxide nanoparticles [19,20,21], calcium oxide nanoparticles [22], zinc oxide and copper oxide nanoparticles [13,23,24]. However, out of all metal oxides or metal composites, silver particles are the most common antibacterial material.
Metals like silver are widely employed as active agents to create antibacterial surfaces due to their potent antibacterial properties, even at extremely low doses [25]. Metals, especially silver (Ag), have long been known as efficient antibacterial compounds capable of destroying bacteria [26]. Hence, silver has been utilized for its antibacterial properties even before the pharmaceutical antibiotic revolution. Polymer–metal composites have evolved as a highly effective technique for various surface applications. These silver polymeric materials can also be used in the form of gels or patches for topical applications such as cosmetics or medicine administration and require a balance of physical strength and antibacterial activity [27]. The biological activity of silver particles is influenced by factors such as surface chemistry, size, shape, particle morphology and composition, coating/capping, agglomeration, and dissolution rate. Additionally, particle reactivity in solution, cell type, and the type of reducing agents used for silver particle synthesis play crucial roles in determining their antibacterial efficacy [28].
The methods for synthesizing silver particles, including biological, chemical, and physical approaches, each have their advantages and disadvantages [29]. For instance, the chemical method uses hazardous materials, generates toxic byproducts, requires a lot of energy, and has the potential to harm the environment [28,29]. The physical synthesis process requires sophisticated equipment and procedures, consumes a lot of energy, lacks stabilizing or capping chemicals to avoid agglomeration, and has limits in managing the size and form of silver particles [28,29]. The most significant advantage of silver particles is their environmental friendliness. Green synthesis approaches use reducing biological agents, such as plant extracts or microbial components, to aid in the reduction of silver ions into silver particles. These approaches frequently remove the requirement for external capping and stabilizing agents, minimizing the usage of potentially dangerous compounds throughout the synthesis process [29]. Furthermore, green synthesis methods are seen as more sustainable and ecofriendly than standard chemical synthesis processes, harmonizing with the worldwide effort to achieve sustainable development goals while lowering environmental impacts [29].
Green synthesis and the antimicrobial activities of silver particles involved in it were investigated extensively in materials such as CS/PVA/Ag [30,31], CS/Ag [32,33,34], PVP/CS/Ag [35], PEG/Ag [36,37], PVP/Ag [38], CS/PEG/Ag [39,40,41], and PVA/Ag [12,33,42]. According to Linh et al. [43], a novel polymeric material, M8, which can inhibit the growth of SA, consists of PVA, PVP, PEG, and CS. Combining the ability to synthesize silver particles using CS, PVA, PVP, and PEG individually and the anti-SA polymer blend M8, in this study, a novel antibacterial agent using silver particles and M8 were synthesized.

2. Materials and Methods

2.1. Materials

All the chemicals were from the same source as previous study [43]. Additionally, silver nitrate (AgNO3, 99.8%) was bought from Shanghai Zhanyun Chemical Co., Ltd. (Shanghai, China). All chemicals were used as received. The School of Biotechnology, International University—Vietnam National University (Ho Chi Minh City, Vietnam) provided Staphylococcus aureus strain ATCC 29523 and Salmonella enterica ATCC 14028. The Research center for Infectious Disease, International University—Vietnam National University (Ho Chi Minh City, Vietnam) provided Pseudomonas aeruginosa strain ATCC 9027.

2.2. Methods

2.2.1. Synthesis of M8/Ag Composite

First, the M8 synthesis was based on the publication [43]. Then, 60 mL of M8 was heated to 80 °C. Specifically, the PVA, PVP, and PEG were separately dissolved in distilled water (DI) at a concentration of 0.02 g/mL. CS was mixed with a 3% acetic acid solution at an amount of 0.01 g/mL. To dissolve polymers completely, stirring and heating for a duration of 40 min was carried out. Next, the polymers using a PVA:PVP:PEG:CS:DI ratio of 1:1:1:1:6 (v/v) were stirred regularly for 1 h to achieve an ideal mixture, referred to as M8. Then, different masses of AgNO3 were added into the polymeric mixture as shown in Table 1.
After adding the silver nitrate, the mixtures were heated and stirred at 80 °C for 6 h. To determine the conversion percentage of Ag+ to Ag0, every hour, the aliquots were measured using UV–Vis spectrophotometer (JASCO V-730, Tokyo, Japan) at a scanning speed of 40 nm/min and the wavelength range of 400 nm to 500. Then, the sample with the highest conversion was allowed to react for 10 h to determine the reaction time required to reach equilibrium.

2.2.2. Characterization

The M8Ag and M8 composite were characterized to investigate their chemical and physical properties. Fourier-transform infrared spectroscopy (FTIR, LUMOS, Bruker, Billerica, MA, USA) was utilized to identify the functional groups present in compounds. Subsequently, field emission scanning electron microscopy (FE-SEM, Hitachi SU8000, Tokyo, Japan) was employed to investigate the surface morphology (particle sizes and shapes). Following this, X-ray diffraction spectroscopy (XRD, Bruker D-76187, Karlsruhe, Germany) was employed to analyze the phase composition and crystal structure of the material. Additionally, energy dispersive X-ray spectroscopy (EDX, JEOL JED-2300, Tokyo, Japan) was used to analyze the elemental composition of the composite.

2.2.3. Antibacterial Activity

First, the culture broth and the bacteria were prepared in a manner similar to that described in our previous publication [43]. From each isolate agar plate, a single morphologically comparable colony was chosen and transferred into a glass tube containing 10 mL of Mueller Hinton broth (Himedia, Maharashtra, India) (MHB). The tubes were incubated at 35 °C for 24 h. Subsequently, optical density at a wavelength of 600 nm (OD600) was measured using Hach DR6000 spectrophotometer (Hach, Loveland, CO, USA), and the bacterial suspension was diluted to achieve an OD600 of 0.01 [44]. This process was repeated for three types of bacteria: SA, PA, and SAL. Then, to determine the minimum inhibition concentration (MIC) and the bactericidal effects, the MIC experiment was performed in a manner similar to that described in the previous publication, without any modifications [43]. After obtaining the inhibition percentage, the three best-performing antibiotic concentrations (M8Ag and M8) were chosen and spread evenly onto separate Mueller Hinton agar plates. Subsequently, the plates were incubated at 35 °C for 24 h, and then we identified the presence of bacteria colonies on each dish.

3. Results and Discussion

3.1. Determining the Conversion Percentage of Ag+ to Ag0 from AgNO3 and M8

Measuring the absorbance at 455 nm, samples with AgNO3 masses ranging from 0.05 to 0.15 g continued to exhibit ongoing reactions after 6 h, achieving a 100% conversion rate, as shown in Figure 1.
The mechanism of converting Ag+ to Ag0 in the M8 polymer blend can be explained as the electron was exchanged. M8 availability was limited, and the increases in the concentrations of AgNO3 caused an increase in Ag+ concentration. Insufficient M8 led to the reduction of Ag+ to Ag0 conversion, which accounted for the observed slope variations and the appearance of two different trends in the graph [45]. The conversion percentage of Ag+ to Ag0 in sample S1 was excessively low, while samples S2 and S3 exhibited large error bars, rendering the data unreliable. Conversely, samples S5, S6, and S7 were deemed unsuitable for further analysis as they were nearing equilibrium, which produces less Ag+ than S4. Hence, sample S4 was determined to be the maximum mass of silver nitrate to obtain 100% conversion of Ag+ to Ag0. However, to determine the equilibrium time to produce Ag0, sample S4 reacted for 10 h.
Figure 2 shows the absorbance of the M8/AgNO3 (S4 sample) solution for 10 h, with absorbance measurements taken at hourly intervals.
As shown in Figure 2, initially, within the first 6 h of the reaction, a rapid increase in absorbance values was observed. This indicated that the reaction between M8 and AgNO3 was proceeding vigorously and with high efficiency during this initial phase. However, after the first 6 h, the rate of growth in absorbance values began to slow down, gradually stabilizing in the subsequent hours. This might suggest the approach of the reaction to the equilibrium state at 10 h. Based on the previous literature, all the components of M8 can reduce Ag+ to Ag0 [12,30,31,32,33,34,35,36,37,38,39,40,41,42]. However, to determine which component can reduce the silver ions the most, the reduction mechanisms, and the synergistic effects between these polymers in the reduction process, further investigation should be conducted in the future.
Afterward, the reflectance percentage of sample S4 from 200 to 700 nm was investigated, as shown in Figure 3.
As illustrated in Figure 3, the S3 composite displayed reflectance in the UV-C range (below 280 nm) ranging from 11% to 31%, below the 11% reflectance in the UV-B range (280–315 nm), and less than the 2% reflectance in the UV-A range (315–400 nm). Reflectance in the visible light spectrum ranged from 2% to 65%. These findings suggested that the material demonstrates moderate reflectivity in visible light.

3.2. Characterization

3.2.1. FE-SEM

Using FE-SEM, the morphology of M8 and M8Ag were determined, as shown in Figure 4.
As shown in Figure 4a, M8 exhibited pores without any discernible small dots. In contrast, M8Ag (Figure 4b) displayed small round dots, indicating the presence of these particles. Using ImageJ software (version 1.53e) and the FE-SEM images shown in Figure 4b, the size and size distribution of the silver particles were determined, as shown in Figure 5.
As shown in Figure 5, the size distribution of particles in M8Ag sample was determined to range from 35 nm to 50 nm, with the highest frequency observed in the 40–45 nm size range. Additionally, there was a noticeable trend towards larger sizes, indicating the presence of a small number of particles exceeding 50 nm. Hence, the average size of the AgNPs was 42.48 ± 10.77 nm. However, to confirm whether these nanoparticles were silver necessitated the use of the XRD method.

3.2.2. XRD

XRD was used to analyze the phase composition and crystal structure of M8 and M8Ag. The XRD analysis is shown in Figure 6.
As shown in Figure 6, the peaks at 2θ values of 38°, 44°, and 65° correspond to the hkl indices of (111), (200), and (220), indicating spherical and crystalline Ag particles [32,46]. Using the Scherrer equation (the shape factor and X-ray wavelength are 0.94 and 1.5406 Å, respectively) [47], the determined average crystallite size of Ag was 44.53 nm, consistent with the results obtained from FE-SEM measurements (42.48 ± 10.77 nm). Hence, using XRD and FE-SEM, silver nanoparticles (AgNPs) were presented in M8–polymer blends consisting of CS, PVA, PEG, and PVP. To be certain, EDX was used once again to identify whether the particles were constituted of Ag and to calculate their percentage inside M8.

3.2.3. EDX

EDX was used to analyze the elemental composition of M8 and M8Ag, as shown in Table 2.
In Table 2, it can be seen that Ag provided 39.22 ± 0.34% of the mass in M8Ag. This suggests that the remainder of the matrix was composed of polymers (PEG, PVP, PVA, and CS). Additionally, M8 exhibits a minimal presence of sodium (Na), silicon (Si), calcium (Ca), and iron (Fe), all below 1%, implying the impurities of the raw materials, as well as the synthesis process, which contributed negligibly to the material’s composition. Conversely, M8Ag reveals the presence of chlorine (Cl) at 0.15 ± 0.02% and potassium (K) at 3.20 ± 0.07%, elements absent in M8. However, during the AgNPs’ synthesis, no chemicals that contain Cl and K were used. Hence, these elements can be considered as contamination during the synthesis. Additionally, the atom fraction of Ag in M8Ag was determined, as shown in Table 3.
As shown in Table 2 and Table 3, and combined with the data from FE-SEM and XRD, 39.22 ± 0.34% (mass fraction) and 8.1 ± 0.07% (atomic fraction) of silver nanoparticles (AgNPs) at the size of 42.48 ± 10.77 nm (FE-SEM) or 44.53 nm (XRD) were presented in M8–polymer blends consisting of CS, PVA, PEG, and PVP.

3.2.4. FTIR

FTIR was utilized to identify the functional groups present in compounds (Figure 7).
For M8, the peak at 3424 cm−1 may correspond to the stretching vibration of -OH groups with primary -NH groups of CS [43,48]. The peak observed at 1640 cm−1 could be attributed to various functional groups, including the C=O stretching vibration of PVP, the bending mode of O-H groups (due to water presence), the C=O stretching vibration of PEG, or the C=O stretching (Amide I) of CS + AA [43,48]. Additionally, the peak at 1104 cm−1 might correspond to the stretching vibrations of C-O bonds, the symmetric stretching of C-O-C in PEG, or the shift of the free amino group (-NH2) at the C2 position of glucosamine in CS + AA [43,48].
Since M8Ag was synthesized based on M8, it shares similarities in the functional groups present in compounds. In contrast, the FTIR spectra of the silver nanoparticles in the M8Ag sample revealed prominent peaks at 2922 cm−1, 1640 cm−1, and 1384 cm−1. A sharp and intense absorption band at 1640 cm−1 was attributed to the stretching vibration of the (NH) C=O group. As mentioned, another much sharper and more intense peak at 1384 cm−1 in the M8Ag compared to M8 indicated the C-C and C-N stretching. Furthermore, the presence of a sharp peak at 2922 cm−1 was assigned to the stretching vibration of C-H and C-H (methoxy compounds). Additionally, in the M8Ag sample, a new distinct peak was found at 824 cm−1. Due to the similarities, it is safe to conclude that in the M8Ag sample, M8 still exists, and some changes in the bonds between the polymers in M8 and the silver particles led to some shifts, increases, and changes in the peaks. This indicated the M8Ag was successfully synthesized.

3.3. Antibacterial Activity

Figure 8 presents the minimum inhibitory concentration (MIC) results for three types of bacteria: SA, SAL, and PA from 5% to 50% dilution.
For SA bacteria, M8Ag had an MIC50 value of 6.25%. Comparing to M8 from previous publication, M8Ag has a smaller MIC50 value [43]. However, M8Ag did not display any inhibitory activity at MIC90, regardless of the dilution percentage. Comparing to the M8 from previous publication, M8Ag has inferior inhibition ability [43]. In the case of SAL bacteria, M8Ag exhibited an MIC50 value of 6.25% and an MIC90 value of 12.5%, indicating its efficacy against SAL bacteria. However, against SAL, M8 has the MIC90 at 25% dilution. This indicates that M8Ag has lower MIC90 than M8. For PA bacteria, M8Ag demonstrated MIC50 and MIC90 values of 6.25%. On the other hand, against PA, M8 does not have MIC90, indicating that M8Ag is superior to M8. Hence, overall, M8Ag is a better antibacterial agent than M8. Notably, from Figure 8, Table 4 focuses on MIC50 and MIC90 results, referring to the minimum concentrations at which 50% and 90% inhibition of bacterial growth were achieved for M8Ag, respectively.
Table 4 clearly indicates that M8Ag exhibited superior antimicrobial activity against SAL and PA compared to SA, due to its lower MIC90 values for inhibiting bacterial growth.
Using MIC results, the aliquots at concentrations of 12.5% and 6.25% dilution were spread on agar plates to assess the bactericidal abilities of M8Ag. The findings revealed that neither dilution concentration could effectively kill SA and SE bacteria, as shown in Table 5.
As shown in Table 5, 6.25% M8Ag demonstrated the ability to eradicate PA bacteria. Based on both MIC and the bactericidal effect results, 6.25% M8Ag exhibited a strong capability to eliminate PA, indicating that PA was the most susceptible bacteria to M8Ag. For SA and SAL, M8Ag only inhibited their growth and did not completely eradicate them.
M8 included PVA, PVP, PEG, and CS. CS and PVA were crucial in their ability to fight against a variety of bacteria [33,43]. However, PVA alone had poor stability in water properties; to overcome this limitation, PVA should be mixed with PVP, which covers the surface particles to produce a stable colloid [43]. The combination of PEG and PVA produced strong interactions via hydrogen bond formation, which improved the mixture’s overall stability and properties [43]. Meanwhile, the PVA/PEG blend decreased adhesion to bacterial surfaces, which added to the particles' antibacterial abilities [49,50]. Specifically, the hydrophilicity of PVA worked as a regulating element, lowering protein adsorption and cell adhesion [49]. Hence, PVA appeared to operate as a barrier against bacterial adherence on the catheter surface [49]. In addition, PEG worked as a reducing agent, speeding up the reduction of silver ions to silver particles and allowing for the efficient production of silver particles with improved antibacterial activity [40].
On the other hand, silver particles released silver ions continuously, acting as a mechanism of antibacterial activity [51]. These ions adhered to cell walls and membranes due to electrostatic attraction and sulfur protein affinity [52]. This adhesion enhanced membrane permeability, disrupting the bacterial envelope. Inside cells, silver ions deactivated respiratory enzymes, generating reactive oxygen species, which halted adenosine triphosphate (ATP) production and caused deoxyribonucleic acid (DNA) modification [51]. The interaction between silver ions and the sulfur and phosphorus components of DNA can disrupt DNA replication and cell reproduction and potentially lead to microbial termination, given the significance of sulfur and phosphorus in DNA’s structure [51].
M8Ag combined the advantages of M8 with Ag particles, considerably increasing its antibacterial efficiency. More specifically, the presence of M8 promoted the conversion of Ag+ to Ag0. In contrast, in an acidic environment (3% acetic acid is used to produce chitosan), bacteria may hydrolyze nearby ester segments and create Ag particles, resulting in enhanced Ag production [52]. As a result, the antibacterial efficiency increases in proportion to the number of Ag particles [51].
Gram-negative bacteria have thinner cellular walls than Gram-positive ones, and the strong cellular wall may limit nanoparticle penetration into cells [53]. Hence, M8Ag was more effective against Gram-negative bacteria. However, while both SAL and PA are Gram-negative bacteria, the antibacterial efficacy of M8Ag against SAL is not as strong as against PA, which was shown in MIC90 and bactericidal effect results. Hence, the antibacterial mechanisms, interaction between the antimicrobial agents and the bacteria, and further investigation for other possible explanations for the aforementioned phenomenon should be the subject of future studies and research. Additionally, researchers should consider studying the cell cytotoxicity and toxicity on mice to provide much deeper understanding of M8Ag.

4. Conclusions

The combination of M8 (including PVA, PVP, PEG, and CS) and silver nitrate created a novel composite (M8Ag) that was environmentally friendly, possessed antibacterial properties, and addressed the issue of antibiotic resistance. M8Ag, with an AgNO3:M8 ratio of 0.15 g/60 mL, achieved 100% conversion of Ag+ to Ag0 after reacting at 80 °C for 10 h. However, the reduction mechanism, as well as determining the main reducing agent(s) in M8, should be investigated in the future.
Silver nanoparticles were successfully synthesized using M8 polymer blends, with a mass fraction of 39.22 ± 0.34% and an atomic fraction of 8.1 ± 0.07. The nanoparticles had a size of 42.48 ± 10.77 nm according to FE-SEM analysis and 44.53 nm based on XRD measurements.
The antibacterial efficacy of M8Ag at diluted concentrations varied across bacterial strains. Specifically, for SA, a concentration of 6.25% was effective at MIC50. SAL exhibited susceptibility at both MIC50 and MIC90, with concentrations of 6.25% and 12.5%, respectively. PA, on the other hand, demonstrated sensitivity at MIC90, with a concentration of 6.25%.
In conclusion, at 6.25% M8Ag, this dilute concentration served as the MIC90 for PA, while for the other two strains, it approached the MIC50 threshold. This suggested that M8Ag exhibited the strongest antibacterial activity against PA. To elucidate further, when spread on agar dishes, 6.25% M8Ag can eliminate PA but not SA and SAL. To elucidate the principle and assess the antibacterial potential of M8Ag against both Gram-negative and Gram-positive bacteria, further investigation into other potential explanations for this observed phenomenon could be pursued as part of future studies. Additionally, the cells’ cytotoxicity and toxicity on mice should be investigated in the future.

Author Contributions

Performing experiment, data analysis, writing—review and editing, K.T.; conceptualization, methodology, data analysis, writing—original draft preparation, writing—review and editing, L.D.; performing experiments, data analysis: Q.N.L. and A.H.H. All authors have read and agreed to the published version of the manuscript.

Funding

No internal and external funding received.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

All data that support the findings of this study are included within the article.

Conflicts of Interest

The authors declare no conflicts of interests.

References

  1. Solar Venero, E.C.; Galeano, M.B.; Luqman, A.; Ricardi, M.M.; Serral, F.; Fernandez Do Porto, D.; Robaldi, S.A.; Ashari, B.A.Z.; Munif, T.H.; Egoburo, D.E.; et al. Fever-like Temperature Impacts on Staphylococcus aureus and Pseudomonas aeruginosa Interaction, Physiology, and Virulence Both in Vitro and in Vivo. BMC Biol. 2024, 22, 27. [Google Scholar] [CrossRef] [PubMed]
  2. Alexander, E.H.; Bento, J.L.; Hughes, F.M.; Marriott, I.; Hudson, M.C.; Bost, K.L. Staphylococcus aureus and Salmonella enterica Serovar Dublin Induce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression by Normal Mouse and Human Osteoblasts. Infect. Immun. 2001, 69, 1581–1586. [Google Scholar] [CrossRef]
  3. DeLeon, S.; Clinton, A.; Fowler, H.; Everett, J.; Horswill, A.R.; Rumbaugh, K.P. Synergistic Interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an In Vitro Wound Model. Infect. Immun. 2014, 82, 4718–4728. [Google Scholar] [CrossRef]
  4. Jfoster, T. Staphylococcus aureus. In Molecular Medical Microbiology; Elsevier: Amsterdam, The Netherlands, 2002; Volume 2, pp. 839–888. ISBN 978-0-12-677530-3. [Google Scholar]
  5. Lowy, F.D. Staphylococcus aureus Infections. N. Engl. J. Med. 1998, 339, 520–532. [Google Scholar] [CrossRef] [PubMed]
  6. Musher, D.M.; Lamm, N.; Darouiche, R.O.; Young, E.J.; Hamill, R.J.; Landon, G.C. The Current Spectrum of Staphylococcus aureus Infection in a Tertiary Care Hospital. Medicine 1994, 73, 186–208. [Google Scholar] [CrossRef] [PubMed]
  7. Taylor, T.A.; Unakal, C.G. Staphylococcus aureus Infection. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2023. [Google Scholar]
  8. Diggle, S.P.; Whiteley, M. Microbe Profile: Pseudomonas aeruginosa: Opportunistic Pathogen and Lab Rat. Microbiology 2020, 166, 30–33. [Google Scholar] [CrossRef]
  9. Percival, S.L.; Williams, D.W. Chapter Ten—Salmonella. In Microbiology of Waterborne Diseases, 2nd ed.; Percival, S.L., Yates, M.V., Williams, D.W., Chalmers, R.M., Gray, N.F., Eds.; Academic Press: London, UK, 2014; pp. 209–222. ISBN 978-0-12-415846-7. [Google Scholar]
  10. Ethelberg, S.; Mølbak, K.; Josefsen, M.H. Bacteria: Salmonella Non-Typhi. In Encyclopedia of Food Safety; Motarjemi, Y., Ed.; Academic Press: Waltham, MA, USA, 2014; pp. 501–514. ISBN 978-0-12-378613-5. [Google Scholar]
  11. Dawoud, T.M.; Shi, Z.; Kwon, Y.M.; Ricke, S.C. Overview of Salmonellosis and Food-Borne Salmonella. In Producing Safe Eggs; Elsevier: Amsterdam, The Netherlands, 2017; pp. 113–138. ISBN 978-0-12-802582-6. [Google Scholar]
  12. Mahmoud, K.H. Synthesis, Characterization, Optical and Antimicrobial Studies of Polyvinyl Alcohol–Silver Nanocomposites. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2015, 138, 434–440. [Google Scholar] [CrossRef]
  13. Jin, T.; Sun, D.; Su, J.Y.; Zhang, H.; Sue, H.-J. Antimicrobial Efficacy of Zinc Oxide Quantum Dots against Listeria monocytogenes, Salmonella Enteritidis, and Escherichia coli O157:H7. J. Food Sci. 2009, 74, M46–M52. [Google Scholar] [CrossRef]
  14. Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial Resistance: A Global Multifaceted Phenomenon. Pathog. Glob. Health 2015, 109, 309–318. [Google Scholar] [CrossRef]
  15. Nanda, A.; Saravanan, M. Biosynthesis of Silver Nanoparticles from Staphylococcus aureus and Its Antimicrobial Activity against MRSA and MRSE. Nanomed. Nanotechnol. Biol. Med. 2009, 5, 452–456. [Google Scholar] [CrossRef]
  16. Li, W.-R.; Xie, X.-B.; Shi, Q.-S.; Duan, S.-S.; Ouyang, Y.-S.; Chen, Y.-B. Antibacterial Effect of Silver Nanoparticles on Staphylococcus aureus. Biometals 2011, 24, 135–141. [Google Scholar] [CrossRef] [PubMed]
  17. Mirzajani, F.; Ghassempour, A.; Aliahmadi, A.; Esmaeili, M.A. Antibacterial Effect of Silver Nanoparticles on Staphylococcus aureus. Res. Microbiol. 2011, 162, 542–549. [Google Scholar] [CrossRef] [PubMed]
  18. Shahverdi, A.R.; Fakhimi, A.; Shahverdi, H.R.; Minaian, S. Synthesis and Effect of Silver Nanoparticles on the Antibacterial Activity of Different Antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 168–171. [Google Scholar] [CrossRef] [PubMed]
  19. Arakha, M.; Pal, S.; Samantarrai, D.; Panigrahi, T.K.; Mallick, B.C.; Pramanik, K.; Mallick, B.; Jha, S. Antimicrobial Activity of Iron Oxide Nanoparticle upon Modulation of Nanoparticle-Bacteria Interface. Sci. Rep. 2015, 5, 14813. [Google Scholar] [CrossRef] [PubMed]
  20. Borcherding, J.; Baltrusaitis, J.; Chen, H.; Stebounova, L.; Wu, C.-M.; Rubasinghege, G.; Mudunkotuwa, I.A.; Carlos Caraballo, J.; Zabner, J.H.; Grassian, V.; et al. Iron Oxide Nanoparticles Induce Pseudomonas aeruginosa Growth, Induce Biofilm Formation, and Inhibit Antimicrobial Peptide Function. Environ. Sci. Nano 2014, 1, 123–132. [Google Scholar] [CrossRef] [PubMed]
  21. Zúñiga-Miranda, J.; Guerra, J.; Mueller, A.; Mayorga-Ramos, A.; Carrera-Pacheco, S.E.; Barba-Ostria, C.; Heredia-Moya, J.; Guamán, L.P. Iron Oxide Nanoparticles: Green Synthesis and Their Antimicrobial Activity. Nanomaterials 2023, 13, 2919. [Google Scholar] [CrossRef] [PubMed]
  22. Ramola, B.; Joshi, N.C. Green Synthesis, Characterisations and Antimicrobial Activities of CaO Nanoparticles. Orient. J. Chem. 2019, 35, 1154–1157. [Google Scholar] [CrossRef]
  23. Azam, A.; Ahmed, A.S.; Oves, M.; Khan, M.S.; Habib, S.S.; Memic, A. Antimicrobial Activity of Metal Oxide Nanoparticles against Gram-Positive and Gram-Negative Bacteria: A Comparative Study. Int. J. Nanomed. 2012, 7, 6003–6009. [Google Scholar] [CrossRef] [PubMed]
  24. Duffy, L.L.; Osmond-McLeod, M.J.; Judy, J.; King, T. Investigation into the Antibacterial Activity of Silver, Zinc Oxide and Copper Oxide Nanoparticles against Poultry-Relevant Isolates of Salmonella and Campylobacter. Food Control 2018, 92, 293–300. [Google Scholar] [CrossRef]
  25. Álvarez-Paino, M.; Muñoz-Bonilla, A.; Fernández-García, M. Antimicrobial Polymers in the Nano-World. Nanomaterials 2017, 7, 48. [Google Scholar] [CrossRef]
  26. Zheng, K.; Setyawati, M.I.; Leong, D.T.; Xie, J. Antimicrobial Silver Nanomaterials. Coord. Chem. Rev. 2018, 357, 1–17. [Google Scholar] [CrossRef]
  27. Mandapalli, P.K.; Labala, S.; Chawla, S.; Janupally, R.; Sriram, D.; Venuganti, V.V.K. Polymer–Gold Nanoparticle Composite Films for Topical Application: Evaluation of Physical Properties and Antibacterial Activity. Polym. Compos. 2017, 38, 2829–2840. [Google Scholar] [CrossRef]
  28. Zhang, X.-F.; Liu, Z.-G.; Shen, W.; Gurunathan, S. Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches. Int. J. Mol. Sci. 2016, 17, 1534. [Google Scholar] [CrossRef]
  29. Nguyen, N.P.U.; Dang, N.T.; Doan, L.; Nguyen, T.T.H. Synthesis of Silver Nanoparticles: From Conventional to ‘Modern’ Methods—A Review. Processes 2023, 11, 2617. [Google Scholar] [CrossRef]
  30. Abdelghany, A.; Abelaziz, M.; Hezma, A.; Elashmawi, I. Spectroscopic and Antibacterial Speculation of Silver Nanoparticles Modified Chitosan/Polyvinyle Alcohol Polymer Blend. Results Phys. 2016, in press. [Google Scholar] [CrossRef]
  31. Wang, L.; Periyasami, G.; Aldalbahi, A.; Fogliano, V. The Antimicrobial Activity of Silver Nanoparticles Biocomposite Films Depends on the Silver Ions Release Behaviour. Food Chem. 2021, 359, 129859. [Google Scholar] [CrossRef] [PubMed]
  32. Kalaivani, R.; Maruthupandy, M.; Muneeswaran, T.; Hameedha Beevi, A.; Anand, M.; Ramakritinan, C.M.; Kumaraguru, A.K. Synthesis of Chitosan Mediated Silver Nanoparticles (Ag NPs) for Potential Antimicrobial Applications. Front. Lab. Med. 2018, 2, 30–35. [Google Scholar] [CrossRef]
  33. Abdallah, O.M.; EL-Baghdady, K.Z.; Khalil, M.M.H.; El Borhamy, M.I.; Meligi, G.A. Antibacterial, Antibiofilm and Cytotoxic Activities of Biogenic Polyvinyl Alcohol-Silver and Chitosan-Silver Nanocomposites. J. Polym. Res. 2020, 27, 74. [Google Scholar] [CrossRef]
  34. Tripathi, S.; Mehrotra, G.K.; Dutta, P.K. Chitosan–Silver Oxide Nanocomposite Film: Preparation and Antimicrobial Activity. Bull. Mater. Sci. 2011, 34, 29–35. [Google Scholar] [CrossRef]
  35. Wang, B.-L.; Liu, X.-S.; Ji, Y.; Ren, K.-F.; Ji, J. Fast and Long-Acting Antibacterial Properties of Chitosan-Ag/Polyvinylpyrrolidone Nanocomposite Films. Carbohydr. Polym. 2012, 90, 8–15. [Google Scholar] [CrossRef]
  36. Khan, B.; Nawaz, M.; Hussain, R.; Price, G.J.; Warsi, M.F.; Waseem, M. Enhanced Antibacterial Activity of Size-Controlled Silver and Polyethylene Glycol Functionalized Silver Nanoparticles. Chem. Pap. 2021, 75, 743–752. [Google Scholar] [CrossRef]
  37. Fahmy, A.; El-Zomrawy, A.; Saeed, A.M.; Sayed, A.Z.; El-Arab, M.A.E.; Shehata, H.A.; Friedrich, J. One-Step Synthesis of Silver Nanoparticles Embedded with Polyethylene Glycol as Thin Films. J. Adhes. Sci. Technol. 2017, 31, 1422–1440. [Google Scholar] [CrossRef]
  38. El Hotaby, W.; Sherif, H.H.A.; Hemdan, B.A.; Khalil, W.A.; Khalil, S.K.H. Assessment of in Situ-Prepared Polyvinylpyrrolidone-Silver Nanocomposite for Antimicrobial Applications. Acta Phys. Pol. A 2017, 131, 1554–1560. [Google Scholar] [CrossRef]
  39. Krishna Rao, K.S.V.; Ramasubba Reddy, P.; Lee, Y.-I.; Kim, C. Synthesis and Characterization of Chitosan–PEG–Ag Nanocomposites for Antimicrobial Application. Carbohydr. Polym. 2012, 87, 920–925. [Google Scholar] [CrossRef] [PubMed]
  40. Mishra, S.K.; Raveendran, S.; Ferreira, J.M.F.; Kannan, S. In Situ Impregnation of Silver Nanoclusters in Microporous Chitosan-PEG Membranes as an Antibacterial and Drug Delivery Percutaneous Device. Langmuir 2016, 32, 10305–10316. [Google Scholar] [CrossRef] [PubMed]
  41. Abdelgawad, A.M.; Hudson, S.M.; Rojas, O.J. Antimicrobial Wound Dressing Nanofiber Mats from Multicomponent (Chitosan/Silver-NPs/Polyvinyl Alcohol) Systems. Carbohydr. Polym. 2014, 100, 166–178. [Google Scholar] [CrossRef] [PubMed]
  42. Pencheva, D.; Bryaskova, R.; Kantardjiev, T. Polyvinyl Alcohol/Silver Nanoparticles (PVA/AgNps) as a Model for Testing the Biological Activity of Hybrid Materials with Included Silver Nanoparticles. Mater. Sci. Eng. C 2012, 32, 2048–2051. [Google Scholar] [CrossRef] [PubMed]
  43. Doan, L.; Tran, K. Relationship between the Polymer Blend Using Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, Polyvinylpyrrolidone, and Antimicrobial Activities against Staphylococcus aureus. Pharmaceutics 2023, 15, 2453. [Google Scholar] [CrossRef] [PubMed]
  44. Wiegand, I.; Hilpert, K.; Hancock, R.E.W. Agar and Broth Dilution Methods to Determine the Minimal Inhibitory Concentration (MIC) of Antimicrobial Substances. Nat. Protoc. 2008, 3, 163–175. [Google Scholar] [CrossRef]
  45. El-Rafie, M.H.; Shaheen, T.I.; Mohamed, A.A.; Hebeish, A. Bio-Synthesis and Applications of Silver Nanoparticles onto Cotton Fabrics. Carbohydr. Polym. 2012, 90, 915–920. [Google Scholar] [CrossRef]
  46. Alginate-Mediated Synthesis of Hetero-Shaped Silver Nanoparticles and Their Hydrogen Peroxide Sensing Ability—PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/31972997/ (accessed on 15 April 2024).
  47. Monshi, A.; Foroughi, M.R.; Monshi, M.R. Modified Scherrer Equation to Estimate More Accurately Nano-Crystallite Size Using XRD. WJNSE 2012, 2, 154–160. [Google Scholar] [CrossRef]
  48. El Farissi, H.; Lakhmiri, R.; Albourine, A.; Safi, M.; Cherkaoui, O. Removal of RR-23 Dye from Industrial Textile Wastewater by Adsorption on Cistus Ladaniferus Seeds and Their Biochar. J. Environ. Earth Sci. 2017, 7. [Google Scholar]
  49. Rafienia, M.; Zarinmehr, B.; Poursamar, S.A.; Bonakdar, S.; Ghavami, M.; Janmaleki, M. Coated Urinary Catheter by PEG/PVA/Gentamicin with Drug Delivery Capability against Hospital Infection. Iran Polym. J. 2013, 22, 75–83. [Google Scholar] [CrossRef]
  50. Barrias, C.C.; Martins, M.C.L.; Almeida-Porada, G.; Barbosa, M.A.; Granja, P.L. The Correlation between the Adsorption of Adhesive Proteins and Cell Behaviour on Hydroxyl-Methyl Mixed Self-Assembled Monolayers. Biomaterials 2009, 30, 307–316. [Google Scholar] [CrossRef] [PubMed]
  51. Yin, I.X.; Zhang, J.; Zhao, I.S.; Mei, M.L.; Li, Q.; Chu, C.H. The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry. Int. J. Nanomed. 2020, 15, 2555–2562. [Google Scholar] [CrossRef]
  52. Luo, L.; Huang, W.; Zhang, J.; Yu, Y.; Sun, T. Metal-Based Nanoparticles as Antimicrobial Agents: A Review. ACS Appl. Nano Mater. 2024, 7, 2529–2545. [Google Scholar] [CrossRef]
  53. Meikle, T.G.; Dyett, B.P.; Strachan, J.B.; White, J.; Drummond, C.J.; Conn, C.E. Preparation, Characterization, and Antimicrobial Activity of Cubosome Encapsulated Metal Nanocrystals. ACS Appl. Mater. Interfaces 2020, 12, 6944–6954. [Google Scholar] [CrossRef]
Figure 1. Absorbance of samples after 6 h at wavelength of 455 nm.
Figure 1. Absorbance of samples after 6 h at wavelength of 455 nm.
Polymers 16 01820 g001
Figure 2. Absorbance of samples for 10 h at wavelength of 455 nm.
Figure 2. Absorbance of samples for 10 h at wavelength of 455 nm.
Polymers 16 01820 g002
Figure 3. Reflectance percentage (200–700 nm) of M8Ag after reacting for 10 h.
Figure 3. Reflectance percentage (200–700 nm) of M8Ag after reacting for 10 h.
Polymers 16 01820 g003
Figure 4. FE-SEM image of (a) M8 and (b) M8Ag.
Figure 4. FE-SEM image of (a) M8 and (b) M8Ag.
Polymers 16 01820 g004
Figure 5. Size distribution of AgNPs in M8Ag composite.
Figure 5. Size distribution of AgNPs in M8Ag composite.
Polymers 16 01820 g005
Figure 6. XRD analysis of M8 and M8Ag composite.
Figure 6. XRD analysis of M8 and M8Ag composite.
Polymers 16 01820 g006
Figure 7. FTIR spectra of M8 and M8Ag.
Figure 7. FTIR spectra of M8 and M8Ag.
Polymers 16 01820 g007
Figure 8. MIC results: the blue line represents MIC50, green line represents MIC90. Triangle, square, and round dots represent PA, SAL, and SA, respectively. Red color and black color represent M8Ag and M8, respectively.
Figure 8. MIC results: the blue line represents MIC50, green line represents MIC90. Triangle, square, and round dots represent PA, SAL, and SA, respectively. Red color and black color represent M8Ag and M8, respectively.
Polymers 16 01820 g008
Table 1. Mass of AgNO3 in M8.
Table 1. Mass of AgNO3 in M8.
SamplesM8 (mL)AgNO3 (g)
S1600.05
S2600.075
S3600.1
S4600.15
S5600.2
S6600.25
S7600.3
Table 2. Mass percentage in M8 and M8Ag.
Table 2. Mass percentage in M8 and M8Ag.
ElementM8 (%)M8Ag (%)
C55.51 ± 0.2218.12 ± 0.11
N4.36 ± 0.279.10 ± 0.25
O39.05 ± 0.4430.20 ± 0.38
Na0.23 ± 0.02-
Si0.53 ± 0.03-
Ca0.10 ± 0.02-
Fe0.23 ± 0.05-
Cl-0.15 ± 0.02
K-3.20 ± 0.07
Ag-39.22 ± 0.34
Total100100
Table 3. Atom percentage in M8 and M8Ag.
Table 3. Atom percentage in M8 and M8Ag.
ElementM8 (%)M8Ag (%)
C62.38 ± 0.2433.57 ± 0.21
N4.2 ± 0.2614.44 ± 0.4
O32.94 ± 0.3742 ± 0.53
Na0.13 ± 0.01-
Si0.26 ± 0.02-
Ca0.03 ± 0.01-
Fe0.06 ± 0.01-
Cl-0.1 ± 0.01
K-1.79 ± 0.04
Ag-8.1 ± 0.07
Total100100
Table 4. MIC results of M8Ag.
Table 4. MIC results of M8Ag.
BacteriaMIC50MIC90
SA6.25%-
SAL6.25%12.5%
PA-6.25%
Table 5. Bactericidal effects of M8Ag (−) and (+) means negative and positive bacteria growth.
Table 5. Bactericidal effects of M8Ag (−) and (+) means negative and positive bacteria growth.
Bacteria12.50%6.25%
SA−+++++
SAL++++++
PA+++−−−
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Doan, L.; Le, Q.N.; Tran, K.; Huynh, A.H. Surface Modifications of Silver Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Antibacterial Agents against Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella enterica. Polymers 2024, 16, 1820. https://doi.org/10.3390/polym16131820

AMA Style

Doan L, Le QN, Tran K, Huynh AH. Surface Modifications of Silver Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Antibacterial Agents against Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella enterica. Polymers. 2024; 16(13):1820. https://doi.org/10.3390/polym16131820

Chicago/Turabian Style

Doan, Linh, Quynh N. Le, Khoa Tran, and An H. Huynh. 2024. "Surface Modifications of Silver Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Antibacterial Agents against Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella enterica" Polymers 16, no. 13: 1820. https://doi.org/10.3390/polym16131820

APA Style

Doan, L., Le, Q. N., Tran, K., & Huynh, A. H. (2024). Surface Modifications of Silver Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Antibacterial Agents against Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella enterica. Polymers, 16(13), 1820. https://doi.org/10.3390/polym16131820

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop